ADIA (Adia Med) OCF Margin %: -31.25% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ADIA Adia Med Inc ADIA
14 GF Score
Price $0.15
! 4 Warning Signs
View Full Analysis

What is Adia Med OCF Margin %?

Adia Med ADIA 14 OCF Margin % is -31.25% as of Mar. 2026. GuruFocus rates ADIA with a GF Score™ of 14/100. The stock has 4 warning signs investors should review. Among 666 Healthcare Providers & Services companies, Adia Med ranks worse than 87.24% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Adia Med's Cash Flow from Operations for the three months ended in Mar. 2026 was $-0.06 Mil. Adia Med's Revenue for the three months ended in Mar. 2026 was $0.18 Mil. Therefore, Adia Med's OCF Margin % for the quarter that ended in Mar. 2026 was -31.25%.

As of today, Adia Med's current OCF Yield % is -1.44%.

The historical rank and industry rank for Adia Med's OCF Margin % or its related term are showing as below:

ADIA' s OCF Margin % Range Over the Past 10 Years
Min: -5583.33   Med: -2804.43   Max: -25.53
Current: -26.96


During the past 2 years, the highest OCF Margin % of Adia Med was -25.53%. The lowest was -5583.33%. And the median was -2804.43%.

ADIA's OCF Margin % is ranked worse than
87.24% of 666 companies
in the Healthcare Providers & Services industry
Industry Median: 8.27 vs ADIA: -26.96


Adia Med OCF Margin % Related Terms


Adia Med OCF Margin % Historical Data

* Premium members only.

The historical data trend for Adia Med's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Adia Med OCF Margin % Chart

Adia Med Annual Data
Trend Dec24 Dec25
OCF Margin %
-5,583.33 -25.53

Adia Med Quarterly Data
Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial -43.06 -99.33 16.76 -95.24 -31.25

ADIA vs GBCS, CCM, CDIX: OCF Margin % Comparison

For the Medical Care Facilities subindustry, Adia Med's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adia Med OCF Margin % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Adia Med's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Adia Med's OCF Margin % falls into.


ADIA
14GF Score
Adia Med Inc ADIA
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Adia Med OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Adia Med's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-0.179/0.701
=-25.53 %

Adia Med's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-0.055/0.176
=-31.25 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -31.25% mean?
Adia Med (ADIA) has a OCF Margin % of -31.25% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Adia Med and its competitors. According to the industry distribution chart, Adia Med ranks #581 out of 666 companies in the Healthcare Providers & Services industry, placing it in the top 87.2%.
Is Adia Med's OCF Margin % too high?
Adia Med's current OCF Margin % is -31.25%. Based on the distribution chart, Adia Med ranks #581 out of 666 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Adia Med has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Adia Med's OCF Margin % compare to GBCS and CCM?
According to the Healthcare Providers & Services industry distribution chart, Adia Med ranks #581 out of 666 companies for OCF Margin %. This places Adia Med in the lower half of its industry. The industry median OCF Margin % is 8.27. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Healthcare Providers & Services company?
The median OCF Margin % among Healthcare Providers & Services companies is 8.27, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Adia Med and its competitors. For the Healthcare Providers & Services industry, the median OCF Margin % is 8.27 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Adia Med's current OCF Margin % is -31.25%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adia Med stock overvalued right now?
Adia Med (ADIA) has a current OCF Margin % of -31.25%. The current OCF Margin % is -31.25%. Adia Med's overall GF Score™ is 14/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Adia Med (ADIA), the current OCF Margin % is -31.25% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Adia Med Business Description

Address 1561 West Fairbanks Avenue, Suite 205, Winter Park, FL, USA, 32789
Adia Nutrition Inc focus is to work closely with healthcare providers and health insurance companies to facilitate and provide Autologous Hematopoietic Stem Cell Transplantation (AHSCT). Its products and the deployment of the therapies utilizing its products address various orthopedic issues, pain management, and wound repair. In addition, its products are able to be utilized in various other therapies to address anti-aging issues and other tissue repair desires. It operates in three segments The Biolete segment comprises the sale of supplements; Adia Med performs stem cell treatments to patients; and Adia Labs procures and sells stem cell products to outside clinics or to Adia Med. It derives revenue from Sales of supplements, Medical procedures, Sales of biologics and ancillary products.
14GF Score

Get the complete analysis for ADIA

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.15
Price